Nebenwirkungen · Remicade
Remicade 100 mg powder for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 21
HOS-089923 · Präparat HOS-083941
Paediatric ulcerative colitis patients Overall, the adverse reactions reported in the paediatric ulcerative colitis trial (C0168T72) and adult ulcerative colitis (ACT 1 and ACT 2) studies were generally consistent. In C0168T72, the most common adverse reactions were upper respiratory tract infection, pharyngitis, abdominal pain, fever, and headache. The most common adverse event was worsening of ulcerative colitis, the incidence of which was higher in patients on the q12 week vs. the q8 week dosing regimen.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-15T13:59:00Z · SHA-256 3fe5ec643ebd8b47f3d2adf8a19ade1224c614e70c07c2d563b0cf68054693ab · Passage 2fd7a3607e40534830376c6ae295d6a2db982f10a78409d1814758aef66be40e · Zeichen 27347–27859 im Abschnitt